By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
IBM's AI progress and dividend yield make it an attractive investment for defensive, income-oriented investors, but growth remains a concern due to legacy software friction and intense competition in the AI space.
Risk: Slow AI monetization and enterprise AI pilot conversion rates could lead to dividend pressure in the long term.
Opportunity: IBM's high dividend yield and potential for AI-driven software cross-sell and monetization could lead to upside if executed successfully.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
International Business Machines Corporation (NYSE:IBM) was one of the stocks featured in Jim Cramer’s Mad Money recap, as he discussed how the AI build-out could power the economy. During the episode, a caller asked if the stock is a buy, sell, or hold. Cramer replied:
I want you to buy IBM. I do not understand why it’s all the way down here. I thought the quarter was actually really good. I think it’s been caught up with this idea that it’s got some software that people don’t like. That’s nonsensical. I think that Arvind Krishna is doing a remarkable job. And yes, I’ll give you the quantum, I’ll throw that in for free.
Credit: IBM
International Business Machines Corporation (NYSE:IBM) provides software, consulting, and cloud and on-site technology solutions, along with financing to help clients use its products. Cramer called it a “terrific buy” during the April 16 episode, as he remarked:
How about the quantum stocks? I believe that one day, quantum computing will be very important, but today is not that day. Right now, the publicly traded companies are just science projects. They all talk a big game. But again, the only viable quantum businesses belong to Google, IBM, and Honeywell. I own Google for the Charitable Trust. I also think IBM’s a terrific buy here.
While we acknowledge the potential of IBM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years** **
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"IBM's current valuation is predicated on a growth narrative that its stagnant top-line revenue and intense competitive landscape fail to support."
Cramer’s endorsement of IBM ignores the structural reality of its pivot. While IBM has successfully transitioned toward a hybrid cloud and AI consulting model, its revenue growth remains anemic, often hovering in the low single digits. The stock is currently trading at roughly 17x forward earnings, a valuation that assumes consistent margin expansion through its 'Consulting' and 'Software' segments. However, IBM faces significant headwinds from enterprise IT budget fatigue and intense competition in the generative AI space from hyperscalers like Microsoft and AWS. Investors are paying for a legacy turnaround story that lacks the explosive top-line acceleration seen in pure-play AI infrastructure providers.
IBM’s massive installed base and high-margin recurring software revenue provide a defensive moat that could outperform if the broader AI hype cycle corrects and investors rotate into value-oriented tech.
"IBM trades at a defensive 18.6x forward P/E with accelerating software/AI growth and a reliable 3.3% yield, making it a smart buy despite Cramer's mixed track record."
IBM's Q1 showed software revenue up 7% to $6.8B (AI/watsonx driven) and consulting up 6%, with Red Hat fueling hybrid cloud momentum—yet total revenue grew just 1.5% to $14.5B amid infrastructure weakness. At 18.6x forward P/E (vs. 14% EPS growth forecast) and 3.3% yield, it's reasonably valued for enterprise AI stability, not hyperscaler growth. Cramer's call ignores modest AI scale ($5B run-rate) but highlights Arvind Krishna's execution. Quantum is hype—irrelevant near-term. Buy for dividend + AI compounding, but cap upside at 20-25% in 12 months if AI bookings accelerate.
IBM's enterprise AI focus means slower adoption and revenue ramps versus Nvidia or hyperscalers, while legacy mainframes and consulting cyclicality expose it to economic slowdowns that pure-play AI stocks dodge.
"A stock falling on good earnings despite a famous bull's endorsement suggests the market sees structural decay that cheerleading won't fix."
Cramer's endorsement is noise, not signal. IBM traded down despite a 'really good' quarter—that's a sell signal, not a buy signal. The market is pricing in structural headwinds (legacy software friction, cloud migration pressure) that a cheerleader's call won't reverse. His quantum computing aside ('not that day') actually undermines the bull case: IBM's quantum is a long-term R&D bet, not a near-term revenue driver. The article itself hedges by pivoting to 'other AI stocks' with 'greater upside'—a tacit admission IBM is defensive, not explosive. Without specifics on Q1 earnings, margin trajectory, or cloud revenue acceleration, this is marketing dressed as analysis.
If IBM's quarter was genuinely strong but the stock fell anyway, that's classic capitulation—institutional selling into good news often precedes reversals. Cramer's contrarian call here (buying weakness) has worked before when the market overreacted to temporary headwinds.
"IBM can outperform if its hybrid cloud and AI monetization scale meaningfully, but execution risk and competition could cap upside."
Jim Cramer's take that 'I want you to buy IBM' taps into AI optimism, but the article glosses over execution risk. IBM's AI progress hinges on monetizing Watsonx and its hybrid cloud services, yet the core business remains weighted toward services and legacy software with slower growth than hyperscalers. The breadth of AI revenue in IBM's mix is still evolving, and near-term margin expansion depends on cost discipline as consultative work shifts to repeatable software. Quantum claims are speculative and likely a long arc. A balanced read is: if IBM can meaningfully lift its software cross-sell and AI monetization, upside could emerge; otherwise, gains may stall.
Against the bullish take: AI spending could remain lumpy and IBM may struggle to translate pilots into durable revenue; the outsized gains in enterprise AI are more likely to go to hyperscalers with scale.
"IBM's dividend yield provides a valuation floor that makes the stock a defensive bond proxy rather than a growth-dependent AI play."
Claude, you’re missing the institutional 'buy-the-dip' dynamic. If IBM’s stock fell on a 'good' quarter, it’s not just institutional capitulation—it’s a classic tax-loss or rotation exit by funds rebalancing into higher-beta AI plays. IBM’s 3.3% dividend yield acts as a hard floor that pure-play AI stocks lack. While growth is anemic, the valuation compression you fear is limited by that yield. IBM isn't a growth stock; it's a high-yield bond proxy with a call option on enterprise AI adoption.
"IBM's high debt and interest burden undermine the dividend yield as a reliable stock floor."
Gemini, your yield floor ignores IBM's $55B net debt and rising interest costs—Q1 expense up 15% YoY to ~$500M amid sticky rates. FCF ($2.7B Q1) covers dividends but leaves thin buffer if enterprise AI pilots convert slowly (only 5% of bookings). Macro IT budget scrutiny risks dividend pressure, as in 2017's near-cut scare.
"IBM's dividend is safe near-term but vulnerable to prolonged AI monetization lag, not immediate debt stress."
Grok's debt math is sound, but misses IBM's refinancing window. At 3.3% yield, IBM can roll $55B debt cheaply if rates stabilize—the 15% expense jump is Q1 noise, not structural. Real risk: if enterprise AI pilots stay at 5% of bookings through 2025, FCF stalls before dividend pressure hits. That's 18-24 months away. Near-term, the yield floor holds. Macro recession kills it faster than rate normalization.
"Debt maturity/refinancing risk could erode IBM's dividend and FCF if AI adoption lags, regardless of a purported refinancing window."
Claude, your 'refinancing window' assumption glosses over real maturity risk. IBM faces sizable upcoming maturities; even with stable rates, refinancing costs and covenants could tighten if AI growth stalls. The bullish view presumes favorable rollovers as a given, but debt maturity timing, potential rating pressure, and capital allocation choices will determine dividend sustainability and FCF. Stress-test a scenario with higher refinancing costs to see if the 3.3% yield covers risk.
IBM's AI progress and dividend yield make it an attractive investment for defensive, income-oriented investors, but growth remains a concern due to legacy software friction and intense competition in the AI space.
IBM's high dividend yield and potential for AI-driven software cross-sell and monetization could lead to upside if executed successfully.
Slow AI monetization and enterprise AI pilot conversion rates could lead to dividend pressure in the long term.